Who owns GlaxoSmithKline?

Key details on GlaxoSmithKline (Ticker: GSK)

Who owns GlaxoSmithKline?

Is GSK a good stock to own? Find out who bought GlaxoSmithKline, who sold GlaxoSmithKline (GSK) stock, and who holds a large position in GlaxoSmithKline.

Fund Name Number of Shares Share Valuation As Of
Gruss & Co 25.33M $547.95M Sept. 30, 2012
Dodge & Cox 12.48M $519.67M June 30, 2015
Hotchkis and Wiley Capital Management 12.21M $522.02M Dec. 31, 2014
Royal Bank of Canada 11.98M $479.32M March 31, 2015
Fisher Investments 11.53M $480.36M June 30, 2015
Wells Fargo & Company 11.06M $510.51M March 31, 2015
FMR 10.98M $457.14M June 30, 2015
Bank of America Corporation 10.92M $502.22M Sept. 30, 2014
STATE STREET CORPORATION 10.50M $437.24M June 30, 2015
JPMORGAN CHASE & CO 9.24M $384.75M June 30, 2015
PRIMECAP Management Company 9.18M $490.37M March 31, 2014
Renaissance Technologies 8.87M $474.34M June 30, 2014
T. Rowe Price Associates 8.78M $405.42M March 31, 2015
Barclays 8.27M $380.51M March 31, 2015
Inves 7.97M $340.61M Dec. 31, 2014
Allianz Asset Management AG 7.74M $357.21M March 31, 2015

Who sold GlaxoSmithKline?

Fund Name Date Sold Number of Shares Sold Share Valuation
Johnson Investment Counsel June 30, 2011 19.93M $947.34M
Allianz Global Investors of America June 30, 2011 10.17M $435.88M
Brandes Investment Partners June 30, 2009 7.69M $271.73M